Literature DB >> 14730507

Kidney-bone, bone-kidney, and cell-cell communications in renal osteodystrophy.

Keith A Hruska1, Georges Saab, Lala R Chaudhary, Cheryl O Quinn, Richard J Lund, Kameswaran Surendran.   

Abstract

The relationship between bone and the kidney in renal osteodystrophy is a complex interplay of kidney to bone connections, bone to kidney connections, and cell to cell connections. In addition, such interactions have a profound effect on the vasculature. In this review, we discuss the role of the bone morphogenetic proteins (BMPs) in the skeleton, kidney, and vasculature. In addition, we propose that deficiencies of these BMPs seen in chronic kidney disease (CKD) result in decreased bone remodeling and a compensatory secondary hyperparathyroidism (high turnover state). Treatment of the hyperparathyroidism blocks this compensatory arm and thus decreased bone remodeling occurs (low turnover). We review animal models of CKD in which treatment with BMP-7 resulted in normalization of both high and low turnover states. Finally, we discuss vascular calcification as it relates to bone metabolism. We discuss the roles of BMP-7 and 2 other bone regulatory proteins, osteoprotegerin (OPG) and alpha2-HS glycoprotein (AHSG, human fetuin), in the human vasculature and their implications for vascular calcification.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14730507     DOI: 10.1053/j.semnephrol.2003.08.010

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  8 in total

Review 1.  The pathogenesis of vascular calcification in the chronic kidney disease mineral bone disorder: the links between bone and the vasculature.

Authors:  Keith A Hruska; Suresh Mathew; Richard J Lund; Imran Memon; Georges Saab
Journal:  Semin Nephrol       Date:  2009-03       Impact factor: 5.299

2.  Uterine sensitization-associated gene-1 (USAG-1), a novel BMP antagonist expressed in the kidney, accelerates tubular injury.

Authors:  Motoko Yanagita; Tomohiko Okuda; Shuichiro Endo; Mari Tanaka; Katsu Takahashi; Fumihiro Sugiyama; Satoshi Kunita; Satoru Takahashi; Atsushi Fukatsu; Masashi Yanagisawa; Toru Kita; Takeshi Sakurai
Journal:  J Clin Invest       Date:  2005-12-08       Impact factor: 14.808

3.  Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome.

Authors:  Mari Tanaka; Misako Asada; Atsuko Y Higashi; Jin Nakamura; Akiko Oguchi; Mayumi Tomita; Sachiko Yamada; Nariaki Asada; Masayuki Takase; Tomohiko Okuda; Hiroshi Kawachi; Aris N Economides; Elizabeth Robertson; Satoru Takahashi; Takeshi Sakurai; Roel Goldschmeding; Eri Muso; Atsushi Fukatsu; Toru Kita; Motoko Yanagita
Journal:  J Clin Invest       Date:  2010-02-08       Impact factor: 14.808

4.  Ibandronate affects bone growth and mineralization in rats with normal and reduced renal function.

Authors:  Dagmar-Christiane Fischer; Claudia Jensen; Anja Rahn; Birgit Salewski; Günther Kundt; Geert J Behets; Patrick D'Haese; Dieter Haffner
Journal:  Pediatr Nephrol       Date:  2010-10-15       Impact factor: 3.714

5.  Achievements and challenges in bioartificial kidney development.

Authors:  Farah Tasnim; Rensheng Deng; Min Hu; Sean Liour; Yao Li; Ming Ni; Jackie Y Ying; Daniele Zink
Journal:  Fibrogenesis Tissue Repair       Date:  2010-08-10

6.  Effects of ADMA upon gene expression: an insight into the pathophysiological significance of raised plasma ADMA.

Authors:  Caroline L Smith; Shelagh Anthony; Mike Hubank; James M Leiper; Patrick Vallance
Journal:  PLoS Med       Date:  2005-10-04       Impact factor: 11.069

7.  Data Mining and Network Pharmacology Analysis of Kidney-Tonifying Herbs on the Treatment of Renal Osteodystrophy Based on the Theory of "Kidney Governing Bones" in Traditional Chinese Medicine.

Authors:  Xue Tong; Yuanjian Yang; Shuwei Gong; Xiao Han; Yanfei Wu; Xiaoran Ma; Shuang Lang; Jianxiong Ma; Xinlong Ma
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-30       Impact factor: 2.650

8.  New Biochemical Serum Markers of Boneturnover in Renal Osteodystrophy.

Authors:  Magdalena Krintus; Agnieszka Pater; Gra Yna Sypniewska; Wies Aw Nowacki
Journal:  EJIFCC       Date:  2004-06-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.